IPTA Responds to EMEA Guidelines
IPTA recently provided comments on two EMEA guidelines that have been put forth for consideration. Each guideline and IPTA comments are provided below.
The Clinical Evaluation of Direct Acting Antiviral Agents Intended for Treatment of Chronic Hepatitis C
Guideline
IPTA's comments
The Clinical Development of Medicinal Products for the Treatment of Cystic Fibrosis
Guideline
IPTA's comments